Cattie Christopher T 4
4 · QNB CORP. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
QNB CORP (QNBC) COO Christopher T. Cattie Receives Restricted Stock Award
What Happened
Christopher T. Cattie, Chief Operating Officer of QNB CORP (QNBC), received restricted stock awards on February 13, 2026 totaling 1,500 shares. The awards were reported at $38.00 per share: one grant of 750 shares ($28,500) and three derivative-designated grants of 250 shares each (3 × $9,500 = $28,500), for a combined reported value of $57,000. This was an award/grant (A), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-02-13; Form filed: 2026-02-18 (filed five days after the transaction; exceeds the typical 2-business-day reporting window).
- Price reported: $38.00 per share.
- Shares issued: 750 (direct) + 3 × 250 (derivative-designated) = 1,500 total.
- Total reported value: $57,000.
- Footnote: F1 — Restricted Stock Award.
- Shares owned after the transaction: not provided in the excerpt of the filing.
Context
These entries are awards of restricted stock (compensation), which are routinely granted to executives and typically vest over time; they are not immediate open-market purchases (which some investors view as stronger bullish signals). The three entries marked as derivative indicate the awards are derivative-designated restricted shares (e.g., restricted stock units or similar structures that convert to common shares on vesting). Note that the Form 4 was filed five days after the transaction date, which appears later than the usual two-business-day reporting requirement.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-13$38.00/sh+750$28,500→ 4,852.017 total - Award
Performance-based restricted stock award
2026-02-13$38.00/sh+250$9,500→ 250 totalExercise: $0.00From: 2026-02-13Exp: 2036-02-13→ Common Stock (250 underlying) - Award
Performance-based restricted stock award
2026-02-13$38.00/sh+250$9,500→ 250 totalExercise: $0.00From: 2027-02-13Exp: 2036-02-13→ Common Stock (250 underlying) - Award
Performance-based restricted stock award
2026-02-13$38.00/sh+250$9,500→ 250 totalExercise: $0.00From: 2028-02-13Exp: 2036-02-13→ Common Stock (250 underlying)
- 3,500
Common Stock(Right to Buy)
Exercise: $37.26From: 2025-02-15Exp: 2027-02-15→ Common Stock (3,500 underlying) - 700
Common Stock(Right to Buy)
Exercise: $29.51From: 2024-02-15Exp: 2033-02-15→ Common Stock (700 underlying) - 700
Common Stock(Right to Buy)
Exercise: $29.51From: 2025-02-15Exp: 2033-02-15→ Common Stock (700 underlying) - 700
Common Stock(Right to Buy)
Exercise: $29.51From: 2026-02-15Exp: 2033-02-15→ Common Stock (700 underlying) - 700
Common Stock(Right to Buy)
Exercise: $29.51From: 2027-02-15Exp: 2033-02-15→ Common Stock (700 underlying) - 700
Common Stock(Right to Buy)
Exercise: $29.51From: 2028-02-15Exp: 2033-02-15→ Common Stock (700 underlying) - 600
Common Stock(Right to Buy)
Exercise: $23.40From: 2025-02-15Exp: 2034-02-15→ Common Stock (600 underlying) - 600
Common Stock(Right to Buy)
Exercise: $23.40From: 2026-02-15Exp: 2034-02-15→ Common Stock (600 underlying) - 600
Common Stock(Right to Buy)
Exercise: $23.40From: 2027-02-15Exp: 2034-02-15→ Common Stock (600 underlying) - 600
Common Stock(Right to Buy)
Exercise: $23.40From: 2028-02-15Exp: 2034-02-15→ Common Stock (600 underlying) - 600
Common Stock(Right to Buy)
Exercise: $23.40From: 2029-02-15Exp: 2034-02-15→ Common Stock (600 underlying) - 860
Common Stock(Right to Buy)
Exercise: $33.50From: 2026-02-14Exp: 2035-02-14→ Common Stock (860 underlying) - 860
Common Stock(Right to Buy)
Exercise: $33.50From: 2027-02-14Exp: 2035-02-14→ Common Stock (860 underlying) - 860
Common Stock(Right to Buy)
Exercise: $33.50From: 2028-02-14Exp: 2035-02-14→ Common Stock (860 underlying) - 860
Common Stock(Right to Buy)
Exercise: $33.50From: 2029-02-14Exp: 2035-02-14→ Common Stock (860 underlying) - 860
Common Stock(Right to Buy)
Exercise: $33.50From: 2030-02-14Exp: 2035-02-14→ Common Stock (860 underlying)
Footnotes (1)
- [F1]Restricted Stock Award